retatrutide triple agonist glp-1 gip glucagon #retatrutide is a novel peptide at the receptor, receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter https://t.co/duYwW0EcmF 🚨 Today, retatrutide, the GIP/GLP-1/glucagon

The bottom line: GLP-1 medications are a powerful tool, and the muscle loss concern while valid is manageable with the right approach

GLP-1 medications are medications that mimic or activate incretin hormone pathways in the body

While some individuals may notice subtle improvements in appetite, sleep, or energy shortly after starting treatment, most benefits develop gradually over time as the body responds to the peptides signaling effects

Adequate Caloric Intake Some patients on GLP-1s eat too little, leading to reduced sex hormones and fatigue

Detailed Protocol

avoid freezethaw cycles of reconstituted solution